Applications published 2 May 2007

Stable suspension formulations of erythropoietin receptor agonists
Alza 1778184*

Pressurised foaming compsn for topical treatment of psoriasis
Galderma 1778185*

Method and preparation of polycyclic and uses thereof
Oncovir 1778186*

Compsns forming non-lamellar dispersions
Camurus 1778187*

Spray-dried powders containing at least one 1,4 O-linked saccharose derivative and methods of producing the same
Boehringer Ingelheim Pharma 1778188*

Use of dry powder compsns for pulmonary delivery
University College Cardiff Consultants 1778189*

Modafinil oral lyophilizate
Cephalon France 1778190*

Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
Protherics Salt Lake City 1778191*

Microparticulate systems for the oral administration of biologically active substances
Universita" Degli Studi di Milano; Universita" Degli Studi di Pavia 1778192*

Sustained release pharmaceutical particulate compsn comprising venlafaxine
KRKA 1778193*

Process for preparing microcrystals
University of Strathclyde 1778194*

Anti-histaminic compsn
Cipla 1778195*

Pharmaceutical dosage forms including rasagiline
Teva Pharmaceutical Industries 1778196*

Compsns and methods for nutrition supplementation
Everett Laboratories 1778197*

Implantable device having controlled release of medication and method of manufacturing the same
Clarity Corp 1778198*

Compressed composite delivery system for release-rate modulation of bioactives
Scolr Pharma 1778199*

Nanocoating for improving biocompatibility of medical implants
Board of Regents, The University of Texas System 1778200*

Extended release pellet formulation containing pramipexaole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
Boehringer Ingelheim International 1778201*

Use of vitamin D receptor activators or vitamin D analogues to treat cardiovascular disease
Abbott Laboratories 1778202*

Apparatus and method for transdermal delivery of naturiuretic peptides
Alza 1778203*

Compsn and methods relating to novel compounds and target thereof
The Regents of the University of Michigan 1778204*

Hydrating compsn
The University Court of the University of Glasgow 1778205*

Small molecule inhibitors of anti-apoptoric BCL-2 family members and the uses thereof
The Regents of the University of Michigan 1778206*

Combination compsns comprising 13-cis-retinyl derivatives and uses thereof to treat ophthalmic disorders
Sytera 1778207*

Extended release capsules comprising venlafaxine hydrochloride
Sherman, Bernard Charles 1778208*

Methods and compsns for oral delivery of FTS
Concordia Pharmaceuticals 1778209*

Lipid-amino acid conjugates and methods of use
University of Massachusetts 1778210*

Methods and materials for treating mental illness
University of Florida Research Foundation 1778211*

Ketogenic saccharides
Ketocytonyx 1778212*

Oligomeric compounds
Ketocytonyx 1778213*

Novel biphenyl compounds and their use
SmithKline Beecham; Cytokinetics 1778214*

Anticancer effect enhancer
Tohoku University 1778215*

Formulation for stimulating hair growth
Warner-Lambert Company 1778216*

Stable injectable compsn of alpha tocopherol succinate, analogues and salts thereof
SD Pharmaceuticals 1778217*

Cholesterol lowering supplement and low cholesterol egg produced by using the same
Jinis Biopharmaceuticals 1778218*

Ascophyllum compsns and methods
Ocean Nutrition Canada 1778219*

Constrained cyano compounds
Phenomix 1778220*

ICE inhibitors for the treatment of autoinflammatory diseases
Vertes Pharmaceuticals 1778221*

Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
Wyeth 1778222*

Methods and compsns for reducing toxicity associated with leflunomide treatment
Williams, James 1778223*

FLT3 inhibitors for immune suppression
The Johns Hopkins University 1778224*

Pyrrolo(oxo)isoquinlines and 5HT ligands
Bristol-Myers Squibb 1778225*

Aerosol formulation for inhalation, containing an anticholinergic agent
Boehringer Ingelheim International 1778226*

Inhalatory medicaments containing corticosteroids, betamimetic agents, and a novel anticholinergenic agent
Boehringer Ingelheim International 1778227*

Therapeutic compound and treatments
Medisyn Technologies 1778228*

Amido compounds and their use as pharmaceuticals
Incyte 1778229*

Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
Boehringer Ingelheim International 1778230*

Chemical compounds
SmithKline Beecham 1778231*

Methods and compsns for inhibiting, destroying, and/or inactivating viruses
SinoFresh HealthCare 1778232*

Intracellular receptor modulator compounds and methods
Ligand Pharmaceuticals 1778233*

Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
Boehringer Ingelheim Vetmedica 1778234*

Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
Shire Holdings 1778235*

Modified pyrimidine glucocorticoid receptor modulators
Corcept Therapeutics 1778236*

Use of aminopterin for treating cancer and inflammatory disorders
Syntrix Biosystems 1778237*

Dihydropteridinone infusion solution having a long shelf life
Boehringer Ingelheim International 1778238*

Adenosine A3 receptor agonists for the treatment of dry eye disorders including Sjogren's Syndrome
Can-Fite Biopharma 1778239*

Dihydropteridiones for the treatment of cancer diseases
Boehringer Ingelheim International 1778240*

Combination of a selective noradrenaline reuptake inhibitor and a PDEV inhibitor
Pfizer 1778241*

Compounds and compsns as modulators of steroid hormone nuclear receptors
IRM LLC 1778242*

Substituted azepine derivatives as serotonin receptor modulators
Athersys 1778243*

Use of N-desmethylclozapine to treat human neuropsychiatric disease
Acadia Pharmaceuticals 1778244*

T type calcium channel blockers and the treatment of diseases
University of Virginia Patent Foundation 1778245*

Pharmaceutical compsn comprising polymorphic forms of dehydroepiandrosterone
Genelabs Technologies 1778246*

Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
Fournier Laboratories Ireland 1778247*